# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA312225 | 53 | EC50 | = | 0.75 | uM | ALA4303815 | 6.12 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
2. | ALA312225 | 53 | Survivors at day 28 | = | 1 | ALA741044 | Mus musculus | |||||
3. | ALA312225 | 53 | Control | = | 0 | % | ALA733876 | % | Mus musculus | |||
4. | ALA312225 | 53 | Control | = | 0.3 | % | ALA733716 | % | Mus musculus | |||
5. | ALA312225 | 53 | Control | = | 14 | % | ALA733714 | % | Mus musculus | |||
6. | ALA312225 | 53 | Control | = | 70 | % | ALA736343 | % | Mus musculus | |||
7. | ALA312225 | 53 | Survivors at day 28 | = | 0.5 | ALA741043 | Mus musculus | |||||
8. | ALA312225 | 53 | Control | = | 27 | % | ALA733717 | % | Mus musculus | |||
9. | ALA312225 | 53 | Control | = | 19 | % | ALA733715 | % | Mus musculus | |||
10. | ALA312225 | 53 | Control | = | 32 | % | ALA733342 | % | Mus musculus | |||
11. | ALA312225 | 53 | Control | = | 102 | % | ALA736344 | % | Mus musculus | |||
12. | ALA312225 | 53 | Viable cells | = | 21 | % | ALA821641 | % | Mus musculus | |||
13. | ALA312225 | 53 | Viable cells | = | 53 | % | ALA821640 | % | Mus musculus | |||
14. | ALA312225 | 53 | Viable cells | = | 92 | % | ALA821639 | % | Mus musculus | |||
15. | ALA312225 | 53 | IC50 | = | 7.5 | uM | ALA764095 | 5.12 | nM | Homo sapiens | ||
16. | ALA312225 | 53 | Viable cells | = | 3 | % | ALA646160 | % | Mus musculus | |||
17. | ALA312225 | 53 | Viable cells | = | 12 | % | ALA646159 | % | Mus musculus | |||
18. | ALA312225 | 53 | Viable cells | = | 72 | % | ALA643179 | % | Mus musculus |